Notification

🚨 Trading Holiday 🚨

The NSE and BSE will remain closed for trading and settlement on Monday, April 14, 2025, on account of Dr. B. R. Ambedkar Jayanti.

Open a Free Demat Account

Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.

Trade Now, Pay Later with up to 4x

Never miss a good trading opportunity due to low funds with our MTF feature.

Track Market Movers Instantly

Stay updated with real-time data. Get insights at your fingertips.

NSE BSE

Trade Nowopens in a new tab

Mirc Electronics Ltd Share Price

₹ 13.85 0.57 (4.29%)

Apr 15 2025 03:29 PM Consumer Durables NSE: MIRCELECTR

Mirc Electronics Ltd Share Price Update

As of the latest trading session, Mirc Electronics Ltd share price is currently at 13.85, which is up by 0.57 from its previous closing. Today, the stock has fluctuated between 13.35 and 13.89. Over the past year, Mirc Electronics Ltd has achieved a return of -35.73 %. In the last month alone, the return has been -5.01 %. Read More...

Mirc Electronics Ltd Performance

Day Range

Low13.35 High13.89

13.80

52 Week Range

Low 11.06 High 32.99

13.80

Mirc Electronics Ltd Share Price

6853

500279

MIRCELECTR

Compare to down-arrow

View

Display

Studies

No Data Available

Open Price

13.40 Prev. Close

13.27 Volume (Shares)

218429.00

Total traded value

30.14 Upper Circuit

13.93 Lower Circuit

12.60

Note: The current prices & values are delayed, Loginopens in a new tab to your account for live updates.

Mirc Electronics Ltd Fundamentals

(Standalone)

Market Cap (Cr)	271.78
PE Ratio (TTM)	-5.61
Book Value / Share	5.65
Beta	1.09

ROE	0.00%
EPS (TTM)	0.00
Dividend Yield	0.00%
Net Profit Qtr (Cr)	-5.27

Mirc Electronics Ltd Financials

Key Results
Key Ratios
Balance sheet
Cash Flow
Competition

Revenue

Net income

Particulars	DEC 2024 (Values in Cr)
Revenue	166.81
Operating Expense	174.66
Net Profit	-5.27
Net Profit Margin (%)	-3.15
Earnings Per Share (EPS)	-0.23
EBITDA	0.79
Effective Tax Rate (%)	0.00

Particulars	SEP 2024 (Values in Cr)
Revenue	151.37
Operating Expense	151.26
Net Profit	1.35
Net Profit Margin (%)	0.89
Earnings Per Share (EPS)	0.06
EBITDA	6.90
Effective Tax Rate (%)	0.00

Particulars	JUN 2024 (Values in Cr)
Revenue	227.79
Operating Expense	228.17
Net Profit	0.44
Net Profit Margin (%)	0.19
Earnings Per Share (EPS)	0.02
EBITDA	5.54
Effective Tax Rate (%)	0.00

Particulars	MAR 2024 (Values in Cr)
Revenue	296.83
Operating Expense	348.62
Net Profit	-51.11
Net Profit Margin (%)	-17.21
Earnings Per Share (EPS)	-2.21
EBITDA	-45.32
Effective Tax Rate (%)	0.00

Particulars	DEC 2023 (Values in Cr)
Revenue	294.51
Operating Expense	293.46
Net Profit	1.55
Net Profit Margin (%)	0.52
Earnings Per Share (EPS)	0.07
EBITDA	7.22
Effective Tax Rate (%)	0.00

Particulars	MAR 2024 (Values in Cr)
Revenue	968.04
Operating Expense	1036.74
Net Profit	-62.21
Net Profit Margin (%)	-6.42
Earnings Per Share (EPS)	-2.69
EBITDA	-39.17
Effective Tax Rate (%)	0.00

Particulars	MAR 2023 (Values in Cr)
Revenue	1110.22
Operating Expense	1125.13
Net Profit	-12.47
Net Profit Margin (%)	-1.12
Earnings Per Share (EPS)	-0.54
EBITDA	7.46
Effective Tax Rate (%)	0.00

Particulars	MAR 2022 (Values in Cr)
Revenue	1192.17
Operating Expense	1200.44
Net Profit	-20.07
Net Profit Margin (%)	-1.68
Earnings Per Share (EPS)	-0.87
EBITDA	1.77
Effective Tax Rate (%)	0.00

Particulars	MAR 2021 (Values in Cr)
Revenue	765.84
Operating Expense	773.99
Net Profit	1.88
Net Profit Margin (%)	0.24
Earnings Per Share (EPS)	0.08
EBITDA	23.51
Effective Tax Rate (%)	0.00

Particulars	MAR 2020 (Values in Cr)
Revenue	604.31
Operating Expense	618.32
Net Profit	-11.46
Net Profit Margin (%)	-1.89
Earnings Per Share (EPS)	-0.50
EBITDA	7.13
Effective Tax Rate (%)	0.00

Particulars	MAR 2016 (Values in Cr)
Book Value / Share	6.71
ROE %	0.00
ROCE %	0.00
Total Debt to Total Equity	1.45
EBITDA Margin	0.03

Particulars	MAR 2015 (Values in Cr)
Book Value / Share	7.70
ROE %	0.00
ROCE %	0.00
Total Debt to Total Equity	1.75
EBITDA Margin	3.35

Particulars	MAR 2014 (Values in Cr)
Book Value / Share	9.08
ROE %	-38.84
ROCE %	-5.35
Total Debt to Total Equity	1.77
EBITDA Margin	-0.57

Particulars	MAR 2013 (Values in Cr)
Book Value / Share	13.46
ROE %	-15.11
ROCE %	-2.43
Total Debt to Total Equity	1.09
EBITDA Margin	0.49

Particulars	MAR 2012 (Values in Cr)
Book Value / Share	15.64
ROE %	-13.99
ROCE %	-0.05
Total Debt to Total Equity	0.65
EBITDA Margin	1.29

Particulars	MAR 2024 (Values in Cr)
Book Value / Share	5.56
ROE %	0.00
ROCE %	0.00
Total Debt to Total Equity	0.58
EBITDA Margin	-4.05

Particulars	MAR 2023 (Values in Cr)
Book Value / Share	8.26
ROE %	0.00
ROCE %	0.00
Total Debt to Total Equity	0.38
EBITDA Margin	0.67

Particulars	MAR 2022 (Values in Cr)
Book Value / Share	8.79
ROE %	0.00
ROCE %	0.00
Total Debt to Total Equity	0.36
EBITDA Margin	1.27

Particulars	MAR 2021 (Values in Cr)
Book Value / Share	9.67
ROE %	-2.53
ROCE %	2.74
Total Debt to Total Equity	0.37
EBITDA Margin	2.04

Particulars	MAR 2020 (Values in Cr)
Book Value / Share	9.60
ROE %	0.00
ROCE %	0.00
Total Debt to Total Equity	0.33
EBITDA Margin	1.18

Particulars	MAR 2016 (Values in Cr)
Cash & Short Term Investments	18.45
Total Assets	589.24
Total Liabilities	589.24
Total Equity	137.56
Share Outstanding	196234202
Price to Book Ratio	1.43
Return on Assets (%)	-3.30
Return on Capital (%)	-5.79

Particulars	MAR 2015 (Values in Cr)
Cash & Short Term Investments	18.81
Total Assets	665.54
Total Liabilities	665.54
Total Equity	151.34
Share Outstanding	196234202
Price to Book Ratio	1.13
Return on Assets (%)	-0.68
Return on Capital (%)	-1.24

Particulars	MAR 2014 (Values in Cr)
Cash & Short Term Investments	27.98
Total Assets	669.58
Total Liabilities	669.58
Total Equity	128.92
Share Outstanding	141752000
Price to Book Ratio	0.50
Return on Assets (%)	-9.27
Return on Capital (%)	-15.48

Particulars	MAR 2013 (Values in Cr)
Cash & Short Term Investments	33.47
Total Assets	723.02
Total Liabilities	723.02
Total Equity	191.05
Share Outstanding	141751678
Price to Book Ratio	0.47
Return on Assets (%)	-4.31
Return on Capital (%)	-6.66

Particulars	MAR 2012 (Values in Cr)
Cash & Short Term Investments	30.52
Total Assets	777.46
Total Liabilities	777.46
Total Equity	221.90
Share Outstanding	141751678
Price to Book Ratio	0.89
Return on Assets (%)	-4.98
Return on Capital (%)	-10.74

Particulars	MAR 2024 (Values in Cr)
Cash & Short Term Investments	15.99
Total Assets	569.84
Total Liabilities	569.84
Total Equity	128.44
Share Outstanding	230952619
Price to Book Ratio	3.42
Return on Assets (%)	-10.91
Return on Capital (%)	-26.91

Particulars	MAR 2023 (Values in Cr)
Cash & Short Term Investments	10.59
Total Assets	529.32
Total Liabilities	529.32
Total Equity	190.84
Share Outstanding	230952619
Price to Book Ratio	1.42
Return on Assets (%)	-2.35
Return on Capital (%)	-4.61

Particulars	MAR 2022 (Values in Cr)
Cash & Short Term Investments	17.77
Total Assets	704.41
Total Liabilities	704.41
Total Equity	203.24
Share Outstanding	230952619
Price to Book Ratio	2.16
Return on Assets (%)	-2.84
Return on Capital (%)	-7.41

Particulars	MAR 2021 (Values in Cr)
Cash & Short Term Investments	28.91
Total Assets	665.36
Total Liabilities	665.36
Total Equity	223.50
Share Outstanding	230952619
Price to Book Ratio	1.42
Return on Assets (%)	0.28
Return on Capital (%)	0.61

Particulars	MAR 2020 (Values in Cr)
Cash & Short Term Investments	6.13
Total Assets	577.46
Total Liabilities	577.46
Total Equity	221.91
Share Outstanding	230952619
Price to Book Ratio	0.42
Return on Assets (%)	-1.98
Return on Capital (%)	-3.87

Particulars	MAR 2024 (Values in Cr)
Net Income	-62.20
Cash from Operations	-3.60
Cash from Investing	-2.20
Cash from Financing	8.00
Net change in Cash	1.24
Free Cash Flow	-1.18

Particulars	MAR 2023 (Values in Cr)
Net Income	-12.46
Cash from Operations	-8.47
Cash from Investing	7.50
Cash from Financing	-0.51
Net change in Cash	-1.77
Free Cash Flow	-7.99

Particulars	MAR 2022 (Values in Cr)
Net Income	-20.07
Cash from Operations	25.53
Cash from Investing	3.32
Cash from Financing	-30.29
Net change in Cash	-2.48
Free Cash Flow	34.30

Particulars	MAR 2021 (Values in Cr)
Net Income	1.88
Cash from Operations	15.91
Cash from Investing	-0.87
Cash from Financing	-7.19
Net change in Cash	7.23
Free Cash Flow	21.72

Particulars	MAR 2020 (Values in Cr)
Net Income	-11.46
Cash from Operations	-4.18
Cash from Investing	0.00
Cash from Financing	-2.02
Net change in Cash	-6.23
Free Cash Flow	-2.94

Company Name	Price	P/E	P/B	Market Cap	52 Week Low/High
ATLAS CYCLE (HARYANA) LTD	84.40	0.00	-1.72	54.89	62.99 / 172.45
BAJAJ ELECT.LTD	509.75	56.70	4.01	5879.57	487.60 / 1120.00
BLUE STAR LIMITED	1967.55	73.72	14.80	40455.74	1345.90 / 2419.95
DELTA MANUFACTURING LTD	62.50	0.00	3.25	67.82	55.16 / 136.85
IFB INDUSTRIES LTD	1291.95	46.73	6.63	5234.98	1020.05 / 2359.00

Company Name	Price	P/E	P/B	Market Cap	52 Week Low/High
ATLAS CYCLE (HARYANA) LTD	84.40	3.62	-2.33	54.89	62.99 / 172.45
BAJAJ ELECT.LTD	509.75	56.70	4.01	5879.57	487.60 / 1120.00
BLUE STAR LIMITED	1967.55	85.88	15.58	40455.74	1345.90 / 2419.95
DELTRON LTD.	11.73	4.81	0.38	3.34	0.00 / 0.00

Technicals

EMA & SMA
Resistance and Support
Price Change Analysis

Bullish Moving Averages -

Bearish Moving Averages -

5 Days 13.00
26 Days 13.60
10 Days 12.90
50 Days 15.30
12 Days 12.90
100 Days 17.70
20 Days 13.20
200 Days 19.50

13.16
PIVOT

First Resistance	13.56
Second Resistance	13.86
Third Resistance	14.26

First Support	12.86
Second Support	12.46
Third Support	12.16

RSI	46.66
MACD	-0.70
Commodity Channel Index (CCI)	35.77

ADX	17.62
Williams % R	-29.62

Mirc Electronics Ltd Future

Future: Price

25 May

0 100 200 300 400 500 600

Discount/Premium

25 May

0 1 2 3 4 5 6 7

Active Calls

25 May

0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul

0 500 1000 1500 2000 2500

Stock Holding

View Live Stock Screeners

Holding

Public

46.42 Promoter Holdings

53.36 FII

0.2 DII

0.0 Promoter Shares(Pledge Percentage)

34.51

Name	Category	Shares	Shares%
Glm Family Trust (gulu Lalchand Mirchandani-in The Capacity Of Trustee)	Shareholding of Promoter and Promoter Group	5.368439E7	23.24
Gulita Securities Ltd	Shareholding of Promoter and Promoter Group	2.7227372E7	11.79
Marissa Vijay Mansukhani	Shareholding of Promoter and Promoter Group	2.5985774E7	11.25
Iifl Investment Adviser & Trustee Services Ltd	Shareholding of Promoter and Promoter Group	1.4175167E7	6.14
Vikram Pratapbhai Kotak	Public Shareholding	2910000.0	1.26
Gita Gulu Mirchandani	Shareholding of Promoter and Promoter Group	1234220.0	0.53
Adino Electronics Ltd	Shareholding of Promoter and Promoter Group	473529.0	0.21
Vijay Mansukhani	Shareholding of Promoter and Promoter Group	350000.0	0.15
G L Mirchandani	Shareholding of Promoter and Promoter Group	100000.0	0.04
Sasha Gulu Mirchandani	Shareholding of Promoter and Promoter Group	6093.0	0.0
Kaval G Mirchandani	Shareholding of Promoter and Promoter Group	6093.0	0.0

Mirc Electronics Ltd

Ex-Date	Dividend Amt.	Dividend Type	Record Date	Instrument Type
2011-06-09	1.0	Final	2011-06-13	Equity shares	2010-06-10	0.95	Final	2010-06-14	Equity shares	2009-08-07	0.4	Final	2009-08-11	Equity shares	2008-06-19	1.0	Final	2008-06-23	Equity shares	2007-03-23	0.75	Interim	2007-03-26	Equity shares	2006-01-16	0.0	Final	2006-01-18	Equity shares

Ex-Date	Ex-Bonus	Ratio
2003-08-16	2003-08-13	1:1

Ex-Date	Old FV	NEW FV	Record Date
2003-12-16	10.0	1.0	2003-12-22

Learn More About Stocks

Dr Reddy’s Denies Workforce Reduction Claims Amid Cost-Cut Rumours

Dr Reddy’s Laboratories rejects claims of reducing workforce costs by 25%, asserting no such plans or internal directives.

15 Apr, 2025 | 3 Min. read

Glenmark, Sun Pharma, Zydus Recall Drugs in US over Compliance Issues

Glenmark, Sun Pharma, and Zydus recall multiple drug batches in the US following manufacturing deviations and contamination concerns as per USFDA enforcement reports.

15 Apr, 2025 | 3 Min. read

HAL Denies Selecting PwC for R&D Benchmarking Amid Ongoing Bids

HAL clarifies no consultancy firm has been finalised for R&D benchmarking amid social media buzz about PwC. Selection process still ongoing via GeM portal.

15 Apr, 2025 | 3 Min. read

Aurobindo Pharma Gets USFDA Nod for Generic Xarelto 2.5mg Tablets

Aurobindo Pharma receives USFDA approval to launch generic Xarelto 2.5mg in Q1 FY26, targeting $447 million US market; higher strengths also gain tentative nod.

15 Apr, 2025 | 3 Min. read

IndiGo Becomes World’s Most Valuable Airline With $23.4 Billion Market Cap

IndiGo surpasses global peers to become the most valuable airline by market cap at $23.4 billion, pushing InterGlobe Aviation share price to record highs in 2025.

11 Apr, 2025 | 3 Min. read

SRF Ltd. Commissions New Agrochemical Unit in Dahej Worth Rs.239 Crore

SRF Ltd. starts new agrochemical facility in Dahej, Gujarat with Rs.239 crore investment. Phase 1 operational, full commissioning set for April 2025.

11 Apr, 2025 | 3 Min. read

Tata Motors’ JLR India Achieves Record Sales in FY25 at 6,183 Units

JLR India posts record-breaking FY25 retail sales of 6,183 units, up 40%. Defender leads growth, boosting Tata Motors share price sentiment.

11 Apr, 2025 | 4 Min. read

Biocon Gets USFDA Approval for Jobevne, Expands Oncology Portfolio

Biocon Biologics receives USFDA nod for cancer drug Jobevne, a bevacizumab biosimilar. Oncology portfolio in US grows, boosting Biocon Ltd. share price outlook.

11 Apr, 2025 | 3 Min. read